$18.72−0.62 (−3.21%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Arteris (AIP) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~16.8%/yr (FY21→FY25), net margin −49.2%. Worth your attention in FY25: Share count (+92.5%) and Capex step-up ($1.4M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲22.3%
70.6
FY21→FY25CAGR +16.8%/yr
Net income ($M)▼3.3%
−34.7
FY21→FY25CAGR —
Free cash flow ($M)—
5.3
capex stepped upCAGR —
Diluted EPS▲4.7%
−0.82
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+92.5%
22.0mn → 42.3mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$1.4M
▲328% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-49¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 90.1% → 90.2%. Net margin -49.2% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 92,981.0 | 70,579.0 | 57,724.0 | 53,666.0 | 50,378.0 | 37,864.0 | ▲22.3% | +16.8% |
Cost of revenue | 12,169.0 | 6,895.0 | 5,962.0 | 5,077.0 | 4,281.0 | 3,731.0 | ▲15.6% | +16.6% |
Gross profit | 80,812.0 | 63,684.0 | 51,762.0 | 48,589.0 | 46,097.0 | 34,133.0 | ▲23.0% | +16.9% |
Research & development | 60,880.0 | 49,908.0 | 45,007.0 | 45,128.0 | 41,167.0 | 30,812.0 | ▲10.9% | +12.8% |
Selling, general & admin | 25,232.0 | 20,131.0 | 17,555.0 | 17,944.0 | 16,367.0 | 13,360.0 | ▲14.7% | +10.8% |
Total operating expenses | 123,803.0 | 96,821.0 | 83,358.0 | 83,731.0 | 74,953.0 | 55,898.0 | ▲16.2% | +14.7% |
Operating incomefeeds ROC rank | −42,991.0 | −33,137.0 | −31,596.0 | −35,142.0 | −28,856.0 | −21,765.0 | ▼4.9% | — |
Other income, net | −866.0 | −134.0 | 458.0 | 3,347.0 | 1,336.0 | −474.0 | — | — |
Pretax income | −43,857.0 | −33,271.0 | −31,138.0 | −31,795.0 | −27,520.0 | −22,239.0 | ▼6.9% | — |
Income tax | −2,175.0 | 1,475.0 | 2,500.0 | 1,677.0 | −417.0 | 1,040.0 | ▼41.0% | +9.1% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −41,682.0 | −34,746.0 | −33,638.0 | −36,869.0 | −27,387.0 | −23,384.0 | ▼3.3% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.89 | −0.82 | −0.86 | −1.03 | −0.84 | −1.06 | ▲4.7% | — |
Diluted shares (mn) | 49.38 | 42.29 | 38.91 | 35.68 | 32.58 | 21.97 | ▲8.7% | +17.8% |
| Margins | ||||||||
Gross margin97th pct in Technology | 86.9% | 90.2% | 89.7% | 90.5% | 91.5% | 90.1% | ▲0.6pp | +0.1pp |
Operating margin | −46.2% | −47.0% | −54.7% | −65.5% | −57.3% | −57.5% | ▲7.8pp | +10.5pp |
Net margin3rd pct in Technology | −44.8% | −49.2% | −58.3% | −68.7% | −54.4% | −61.8% | ▲9.0pp | +12.5pp |
† TTM = trailing four quarters through 2026-09-30.
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Arteris' revenue last fiscal year?
Arteris reported revenue of $70.6M in fiscal 2025, up 22.3% from fiscal 2024.
What was Arteris' net income?
Arteris reported net income of −$34.7M in fiscal 2025, a net margin of −49.2%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

